Key Highlights: Implications: This partnership accelerates peptide therapy access in high-growth markets, challenging incumbents like Sun Pharma in India’s $500M+ peptide segment whi...
Key Highlights: Implications: Durvalumab storms earlier gastric cancer treatment, snatching share from chemo-only protocols as oncologists embrace immunotherapy combo superiority.&nb...
Clinical Trials in India: Growth, Ethics & Global Positioning Recent Industry Context Clinical trials have always been a crucial pillar of healthcare innovation, acting as the bridge b...
Key Highlights: Implications: Jubilant catapults into top-tier CRO/CDMO contender, snatching complex molecule work from Lonza/Capricor as India chemistry talent goes global. Noid...
Key Highlights: Implications: The appointment underlines ChemWerth’s intent to treat India not just as a sourcing base but as a strategic growth market for its re...
Latest Developments in Pharma Partnerships and Acquisitions India’s pharmaceutical industry has evolved into one of the most dynamic and globally integrated sectors in healthcare. As companies s...
